How This Manufacturer Turned Big Pharma's Commercialization Model Upside Down

When Pfizer acquired Biohaven for $11.6 billion, many big Pharma executives began to question their own beliefs and commercial tactics.

Related Keywords

Connecticut ,United States ,Yale University ,Khloe Kardashian ,Newamsterdam Pharma ,Abbvie Ubrelvy ,Pfizer ,Biohaven Pharmaceutical Holding Company Ltd ,Vlad Coric ,Bristol Myers Squibb ,Chief Commercial Officer ,Nurtec Odt ,Biohaven ,Pharma Commercialization ,Big Pharma ,Bj Jones ,